{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:36:20Z","timestamp":1788467780875,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40122-022-00465-y","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T19:02:26Z","timestamp":1673636546000},"page":"355-375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks"],"prefix":"10.1007","volume":"12","author":[{"given":"Samuel P.","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Sidharthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyeaka","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vwaire","family":"Orhurhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"465_CR1","unstructured":"Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for Transforming Prevention, care, education, and research. National Academies Press (US); 2011. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK91497\/. Accessed 28 Sep 2020."},{"issue":"6","key":"465_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/acr.23425","volume":"70","author":"LB Murphy","year":"2018","unstructured":"Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res (Hoboken). 2018;70(6):869\u201376. https:\/\/doi.org\/10.1002\/acr.23425.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"18","key":"465_CR3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1001\/jama.290.18.2443","volume":"290","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443\u201354. https:\/\/doi.org\/10.1001\/jama.290.18.2443.","journal-title":"JAMA"},{"issue":"3 Suppl","key":"465_CR4","doi-asserted-by":"publisher","first-page":"ES67","DOI":"10.36076\/ppj.2012\/15\/ES67","volume":"15","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3 Suppl):ES67-92.","journal-title":"Pain Physician"},{"issue":"7","key":"465_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.18553\/jmcp.2009.15.7.556","volume":"15","author":"SA Strassels","year":"2009","unstructured":"Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15(7):556\u201362. https:\/\/doi.org\/10.18553\/jmcp.2009.15.7.556.","journal-title":"J Manag Care Pharm"},{"issue":"1 Suppl B","key":"465_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18553\/jmcp.2010.16.s1-b.9","volume":"16","author":"C Ruetsch","year":"2010","unstructured":"Ruetsch C. Empirical view of opioid dependence. J Manag Care Pharm. 2010;16(1 Suppl B):9\u201313. https:\/\/doi.org\/10.18553\/jmcp.2010.16.s1-b.9.","journal-title":"J Manag Care Pharm."},{"issue":"7","key":"465_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jama.2013.272","volume":"309","author":"CM Jones","year":"2013","unstructured":"Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657\u20139. https:\/\/doi.org\/10.1001\/jama.2013.272.","journal-title":"JAMA"},{"issue":"39","key":"465_CR8","first-page":"849","volume":"63","author":"RA Rudd","year":"2014","unstructured":"Rudd RA, Paulozzi LJ, Bauer MJ, et\u00a0al. Increases in heroin overdose deaths\u201428 states, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014;63(39):849\u201354.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"465_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66(34):897\u2013903. https:\/\/doi.org\/10.15585\/mmwr.mm6634a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"465_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419\u201327. https:\/\/doi.org\/10.15585\/mmwr.mm675152e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"465_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/EDBK_100020","volume":"39","author":"S Dalal","year":"2019","unstructured":"Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. Am Soc Clin Oncol Educ Book. 2019;39:24\u201335. https:\/\/doi.org\/10.1200\/EDBK_100020.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"465_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113871","volume":"156","author":"CG Virgen","year":"2022","unstructured":"Virgen CG, Kelkar N, Tran A, et\u00a0al. Pharmacological management of cancer pain: novel therapeutics. Biomed Pharmacother. 2022;156: 113871. https:\/\/doi.org\/10.1016\/j.biopha.2022.113871.","journal-title":"Biomed Pharmacother"},{"key":"465_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012592.pub2","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain\u2014an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7: CD012592. https:\/\/doi.org\/10.1002\/14651858.CD012592.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"465_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jama.2017.0935","volume":"317","author":"DW Baker","year":"2017","unstructured":"Baker DW. History of the joint commission\u2019s pain standards: lessons for today\u2019s prescription opioid epidemic. JAMA. 2017;317(11):1117\u20138. https:\/\/doi.org\/10.1001\/jama.2017.0935.","journal-title":"JAMA"},{"issue":"6","key":"465_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jamcollsurg.2020.08.771","volume":"231","author":"M El Moheb","year":"2020","unstructured":"El Moheb M, Mokhtari A, Han K, et\u00a0al. Pain or no pain, we will give you opioids: relationship between number of opioid pills prescribed and severity of pain after operation in US vs non-US patients. J Am Coll Surg. 2020;231(6):639\u201348. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.08.771.","journal-title":"J Am Coll Surg"},{"key":"465_CR16","unstructured":"Cohen B, Ruth LJ, Preuss CV. Opioid analgesics. In: StatPearls. StatPearls Publishing; 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459161\/. Accessed 25 Oct 2022."},{"issue":"3","key":"465_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/mcrocq","volume":"22","author":"MA Crocq","year":"2020","unstructured":"Crocq MA. History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci. 2020;22(3):223\u20138. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/mcrocq.","journal-title":"Dialogues Clin Neurosci"},{"key":"465_CR18","unstructured":"Grinspoon L, Bakalar JB. Marijuana, the forbidden medicine. Rev. and exp. edn. Yale University Press; 1997."},{"issue":"3","key":"465_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1037\/adb0000111","volume":"29","author":"J Bestrashniy","year":"2015","unstructured":"Bestrashniy J, Winters KC. Variability in medical marijuana laws in the United States. Psychol Addict Behav. 2015;29(3):639\u201342. https:\/\/doi.org\/10.1037\/adb0000111.","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"465_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.mayocp.2011.10.003","volume":"87","author":"JM Bostwick","year":"2012","unstructured":"Bostwick JM. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc. 2012;87(2):172\u201386. https:\/\/doi.org\/10.1016\/j.mayocp.2011.10.003.","journal-title":"Mayo Clin Proc"},{"key":"465_CR21","unstructured":"World Health Organization. Division of Mental Health and Prevention of Substance Abuse & WHO Expert Working Group on Health Effects of Cannabis Use (1996: Geneva, Switzerland). (1997). Cannabis : a health perspective and research agenda.\u00a0World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/63691."},{"issue":"6","key":"465_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jpain.2016.02.007","volume":"17","author":"SR Savage","year":"2016","unstructured":"Savage SR, Romero-Sandoval A, Schatman M, et\u00a0al. Cannabis in pain treatment: clinical and research considerations. J Pain. 2016;17(6):654\u201368. https:\/\/doi.org\/10.1016\/j.jpain.2016.02.007.","journal-title":"J Pain"},{"issue":"Suppl 1","key":"465_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","volume":"20","author":"K Mackie","year":"2008","unstructured":"Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008;20(Suppl 1):10\u20134. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01671.x.","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"465_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","volume":"76","author":"PE Castillo","year":"2012","unstructured":"Castillo PE, Younts TJ, Ch\u00e1vez AE, Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron. 2012;76(1):70\u201381. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.020.","journal-title":"Neuron"},{"key":"465_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107495","volume":"209","author":"CA Bouchet","year":"2020","unstructured":"Bouchet CA, Ingram SL. Cannabinoids in the descending pain modulatory circuit: role in inflammation. Pharmacol Ther. 2020;209: 107495. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107495.","journal-title":"Pharmacol Ther"},{"key":"465_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","volume":"80","author":"K Starowicz","year":"2017","unstructured":"Starowicz K, Finn DP. Cannabinoids and pain: sites and mechanisms of action. Adv Pharmacol. 2017;80:437\u201375. https:\/\/doi.org\/10.1016\/bs.apha.2017.05.003.","journal-title":"Adv Pharmacol"},{"key":"465_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","volume":"9","author":"S Vu\u010dkovi\u0107","year":"2018","unstructured":"Vu\u010dkovi\u0107 S, Srebro D, Vujovi\u0107 KS, Vu\u010deti\u0107 \u010c, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259. https:\/\/doi.org\/10.3389\/fphar.2018.01259.","journal-title":"Front Pharmacol"},{"issue":"7045","key":"465_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nature03658","volume":"435","author":"AG Hohmann","year":"2005","unstructured":"Hohmann AG, Suplita RL, Bolton NM, et\u00a0al. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005;435(7045):1108\u201312. https:\/\/doi.org\/10.1038\/nature03658.","journal-title":"Nature"},{"key":"465_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ynstr.2014.09.006","volume":"1","author":"RJ Valentino","year":"2014","unstructured":"Valentino RJ, Van Bockstaele E. Endogenous opioids: the downside of opposing stress. Neurobiol Stress. 2014;1:23\u201332. https:\/\/doi.org\/10.1016\/j.ynstr.2014.09.006.","journal-title":"Neurobiol Stress"},{"issue":"3","key":"465_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et\u00a0al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3): e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"issue":"10","key":"465_CR31","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanp\u00e4\u00e4 M, et\u00a0al. A new definition of neuropathic pain. Pain. 2011;152(10):2204\u20135. https:\/\/doi.org\/10.1016\/j.pain.2011.06.017.","journal-title":"Pain"},{"issue":"5","key":"465_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0036-1584950","volume":"36","author":"J Gierthm\u00fchlen","year":"2016","unstructured":"Gierthm\u00fchlen J, Baron R. Neuropathic pain. Semin Neurol. 2016;36(5):462\u20138. https:\/\/doi.org\/10.1055\/s-0036-1584950.","journal-title":"Semin Neurol"},{"key":"465_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012182.pub2","volume":"3","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Phillips T, Radbruch L, Petzke F, H\u00e4user W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3: CD012182. https:\/\/doi.org\/10.1002\/14651858.CD012182.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"465_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O Van Hecke","year":"2014","unstructured":"Van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654\u201362. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013.","journal-title":"Pain"},{"key":"465_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7339","volume":"347","author":"E Kalso","year":"2013","unstructured":"Kalso E, Aldington DJ, Moore RA. Drugs for neuropathic pain. BMJ. 2013;347: f7339. https:\/\/doi.org\/10.1136\/bmj.f7339.","journal-title":"BMJ"},{"issue":"24","key":"465_CR36","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et\u00a0al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456\u201373. https:\/\/doi.org\/10.1001\/jama.2015.6358.","journal-title":"JAMA"},{"issue":"12","key":"465_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","volume":"16","author":"MH Andreae","year":"2015","unstructured":"Andreae MH, Carter GM, Shaparin N, et\u00a0al. Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain. 2015;16(12):1221\u201332. https:\/\/doi.org\/10.1016\/j.jpain.2015.07.009.","journal-title":"J Pain"},{"issue":"1","key":"465_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11607\/ofph.1274","volume":"29","author":"DG Boychuk","year":"2015","unstructured":"Boychuk DG, Goddard G, Mauro G, Orellana MF. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. J Oral Facial Pain Headache. 2015;29(1):7\u201314. https:\/\/doi.org\/10.11607\/ofph.1274.","journal-title":"J Oral Facial Pain Headache"},{"issue":"5","key":"465_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","volume":"72","author":"ME Lynch","year":"2011","unstructured":"Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72(5):735\u201344. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03970.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"465_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00482-015-0089-y","volume":"30","author":"F Petzke","year":"2016","unstructured":"Petzke F, Enax-Krumova EK, H\u00e4user W. Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: a systematic review of randomized controlled studies. Schmerz. 2016;30(1):62\u201388. https:\/\/doi.org\/10.1007\/s00482-015-0089-y.","journal-title":"Schmerz"},{"issue":"2","key":"465_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et\u00a0al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(14)70251-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"465_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40122-021-00235-2","volume":"10","author":"SN El-Tallawy","year":"2021","unstructured":"El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JAK, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021;10(1):181\u2013209. https:\/\/doi.org\/10.1007\/s40122-021-00235-2.","journal-title":"Pain Ther"},{"issue":"1","key":"465_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/j.pain.0000000000001389","volume":"160","author":"S Perrot","year":"2019","unstructured":"Perrot S, Cohen M, Barke A, et\u00a0al. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019;160(1):77\u201382. https:\/\/doi.org\/10.1097\/j.pain.0000000000001389.","journal-title":"Pain"},{"issue":"6","key":"465_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1503\/cjs.001018","volume":"62","author":"K Madden","year":"2019","unstructured":"Madden K, George A, van der Hoek NJ, Borim FM, Mammen G, Bhandari M. Cannabis for pain in orthopedics: a systematic review focusing on study methodology. Can J Surg. 2019;62(6):369\u201380. https:\/\/doi.org\/10.1503\/cjs.001018.","journal-title":"Can J Surg"},{"key":"465_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060807","author":"I Sagy","year":"2019","unstructured":"Sagy I, Bar-Lev Schleider L, Abu-Shakra M, Novack V. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8060807.","journal-title":"J Clin Med"},{"issue":"1","key":"465_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42238-020-00024-2","volume":"2","author":"EC Cameron","year":"2020","unstructured":"Cameron EC, Hemingway SL. Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015\u20132019). J Cannabis Res. 2020;2(1):19. https:\/\/doi.org\/10.1186\/s42238-020-00024-2.","journal-title":"J Cannabis Res"},{"issue":"1","key":"465_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","volume":"30","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Baerwald C, Ablin J, H\u00e4user W. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials. Schmerz. 2016;30(1):47\u201361. https:\/\/doi.org\/10.1007\/s00482-015-0084-3.","journal-title":"Schmerz"},{"issue":"9","key":"465_CR48","first-page":"671","volume":"81","author":"GE Ehrlich","year":"2003","unstructured":"Ehrlich GE. Low back pain. Bull World Health Organ. 2003;81(9):671\u20136.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"465_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/can.2019.0077","volume":"5","author":"L First","year":"2020","unstructured":"First L, Douglas W, Habibi B, Singh JR, Sein MT. Cannabis use and low-back pain: a systematic review. Cannabis Cannabinoid Res. 2020;5(4):283\u20139. https:\/\/doi.org\/10.1089\/can.2019.0077.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"465_CR50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-4040.72250","volume":"1","author":"A Gupta","year":"2010","unstructured":"Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RSR. Clinical aspects of acute post-operative pain management & its assessment. J Adv Pharm Technol Res. 2010;1(2):97\u2013108.","journal-title":"J Adv Pharm Technol Res"},{"issue":"S1","key":"465_CR51","doi-asserted-by":"publisher","first-page":"320S","DOI":"10.1002\/j.1552-4604.1981.tb02610.x","volume":"21","author":"AK Jain","year":"1981","unstructured":"Jain AK, Ryan JR, McMahon FG, Smith G. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol. 1981;21(S1):320S-326S. https:\/\/doi.org\/10.1002\/j.1552-4604.1981.tb02610.x.","journal-title":"J Clin Pharmacol"},{"issue":"1\u20132","key":"465_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0304-3959(03)00331-2","volume":"106","author":"DJ Buggy","year":"2003","unstructured":"Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain. 2003;106(1\u20132):169\u201372. https:\/\/doi.org\/10.1016\/s0304-3959(03)00331-2.","journal-title":"Pain"},{"issue":"8","key":"465_CR53","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/BF03022793","volume":"53","author":"P Beaulieu","year":"2006","unstructured":"Beaulieu P. Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Can J Anesth. 2006;53(8):769\u201375. https:\/\/doi.org\/10.1007\/BF03022793.","journal-title":"Can J Anesth"},{"issue":"3","key":"465_CR54","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1213\/ANE.0000000000003963","volume":"129","author":"CW Liu","year":"2019","unstructured":"Liu CW, Bhatia A, Buzon-Tan A, et\u00a0al. Weeding out the problem: the impact of preoperative cannabinoid use on pain in the perioperative period. Anesth Analg. 2019;129(3):874\u201381. https:\/\/doi.org\/10.1213\/ANE.0000000000003963.","journal-title":"Anesth Analg"},{"issue":"2","key":"465_CR55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00000542-200702000-00028","volume":"106","author":"P Beaulieu","year":"2007","unstructured":"Beaulieu P. Cannabinoids for postoperative pain. Anesthesiology. 2007;106(2):397\u2013397. https:\/\/doi.org\/10.1097\/00000542-200702000-00028.","journal-title":"Anesthesiology"},{"issue":"7","key":"465_CR56","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/rapm-2020-101475","volume":"45","author":"JD Meeker","year":"2020","unstructured":"Meeker JD, Ayrian E, Mariano ER. Daring discourse\u2014no: cannabinoids should not be used for acute postoperative pain management. Reg Anesth Pain Med. 2020;45(7):520\u20133. https:\/\/doi.org\/10.1136\/rapm-2020-101475.","journal-title":"Reg Anesth Pain Med"},{"key":"465_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd003868.pub3","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.cd003868.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9784","key":"465_CR58","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/s0140-6736(11)60236-5","volume":"377","author":"RK Portenoy","year":"2011","unstructured":"Portenoy RK. Treatment of cancer pain. Lancet. 2011;377(9784):2236\u201347. https:\/\/doi.org\/10.1016\/s0140-6736(11)60236-5.","journal-title":"Lancet"},{"issue":"2\u20133","key":"465_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/j.1552-4604.1975.tb02348.x","volume":"15","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Baram DA, et\u00a0al. Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol. 1975;15(2\u20133):139\u201343. https:\/\/doi.org\/10.1002\/j.1552-4604.1975.tb02348.x.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"465_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cpt197518184","volume":"18","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Avery DA, et\u00a0al. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 1975;18(1):84\u20139. https:\/\/doi.org\/10.1002\/cpt197518184.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"465_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cpt1978242223","volume":"24","author":"PR Jochimsen","year":"1978","unstructured":"Jochimsen PR, Lawton RL, VerSteeg K, et\u00a0al. Effect of benzopyranoperidine, a \u0394-9-THC congener on pain. Clin Pharmacol Ther. 1978;24(2):223\u20137. https:\/\/doi.org\/10.1002\/cpt1978242223.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"465_CR62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt1978234397","volume":"23","author":"M Staquet","year":"1978","unstructured":"Staquet M, Gantt C, Machin D. Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther. 1978;23(4):397\u2013401. https:\/\/doi.org\/10.1002\/cpt1978234397.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"465_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, et\u00a0al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167\u201379. https:\/\/doi.org\/10.1016\/j.jpainsymman.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"465_CR64","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S, et\u00a0al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438\u201349. https:\/\/doi.org\/10.1016\/j.jpain.2012.01.003.","journal-title":"J Pain"},{"key":"465_CR65","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3293","author":"A Ali","year":"2018","unstructured":"Ali A, Arif AW, Bhan C, et\u00a0al. Managing chronic pain in the elderly: an overview of the recent therapeutic advancements. Cureus. 2018. https:\/\/doi.org\/10.7759\/cureus.3293.","journal-title":"Cureus"},{"key":"465_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnw166","author":"B Kaskie","year":"2017","unstructured":"Kaskie B, Ayyagari P, Milavetz G, et\u00a0al. The increasing use of cannabis among older Americans: a public health crisis or viable policy alternative? Gerontologist. 2017. https:\/\/doi.org\/10.1093\/geront\/gnw166.","journal-title":"Gerontologist"},{"issue":"4","key":"465_CR67","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","volume":"180","author":"BH Han","year":"2020","unstructured":"Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015\u20132018. JAMA Intern Med. 2020;180(4):609. https:\/\/doi.org\/10.1001\/jamainternmed.2019.7517.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"465_CR68","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/jcm8111819","volume":"8","author":"R Abuhasira","year":"2019","unstructured":"Abuhasira R, Ron A, Sikorin I, et\u00a0al. Medical cannabis for older patients\u2014treatment protocol and initial results. J Clin Med. 2019;8(11):1819. https:\/\/doi.org\/10.3390\/jcm8111819.","journal-title":"J Clin Med"},{"issue":"9","key":"465_CR69","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ejp.1297","volume":"22","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user W, Finn DP, Kalso E, et\u00a0al. European pain federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain. 2018;22(9):1547\u201364. https:\/\/doi.org\/10.1002\/ejp.1297.","journal-title":"Eur J Pain"},{"key":"465_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","volume":"49","author":"R Abuhasira","year":"2018","unstructured":"Abuhasira R, Schleider LB, Mechoulam R, et\u00a0al. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. Eur J Intern Med. 2018;49:44\u201350. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.019.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"465_CR71","doi-asserted-by":"publisher","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","volume":"20","author":"J Aviram","year":"2017","unstructured":"Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2017;20(6):E755\u201396.","journal-title":"Pain Physician"},{"issue":"9","key":"465_CR72","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/nejmc1407928","volume":"371","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, et\u00a0al. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):878\u20139. https:\/\/doi.org\/10.1056\/nejmc1407928.","journal-title":"N Engl J Med"},{"issue":"3","key":"465_CR73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","volume":"19","author":"G Lafaye","year":"2017","unstructured":"Lafaye G, Karila L, Blecha L, Benyamina A. Cannabis, cannabinoids, and health. Dialogues Clin Neurosci. 2017;19(3):309\u201316. https:\/\/doi.org\/10.31887\/DCNS.2017.19.3\/glafaye.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1\u20132","key":"465_CR74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","volume":"115","author":"C Lopez-Quintero","year":"2011","unstructured":"Lopez-Quintero C, de losCobos JP, Hasin DS, et\u00a0al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Dependence. 2011;115(1\u20132):120\u201330. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.11.004.","journal-title":"Drug Alcohol Dependence."},{"issue":"8","key":"465_CR75","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","volume":"170","author":"DS Hasin","year":"2013","unstructured":"Hasin DS, O\u2019Brien CP, Auriacombe M, et\u00a0al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834\u201351. https:\/\/doi.org\/10.1176\/appi.ajp.2013.12060782.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"465_CR76","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","volume":"173","author":"DS Hasin","year":"2016","unstructured":"Hasin DS, Kerridge BT, Saha TD, et\u00a0al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the national epidemiologic survey on alcohol and related conditions\u2013iii. Am J Psychiatry. 2016;173(6):588\u201399. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15070907.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"465_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00952990.2013.772618","volume":"39","author":"L Fl\u00f3rez-Salamanca","year":"2013","unstructured":"Fl\u00f3rez-Salamanca L, Secades-Villa R, Hasin DS, et\u00a0al. Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Drug Alcohol Abuse. 2013;39(3):168\u201379. https:\/\/doi.org\/10.3109\/00952990.2013.772618.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"465_CR78","first-page":"56","volume":"50","author":"I Urits","year":"2020","unstructured":"Urits I, Gress K, Charipova K, et\u00a0al. Cannabis use and its association with psychological disorders. Psychopharmacol Bull. 2020;50(2):56\u201367.","journal-title":"Psychopharmacol Bull"},{"key":"465_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2017.09.032","volume":"181","author":"BT Kerridge","year":"2017","unstructured":"Kerridge BT, Mauro PM, Chou SP, et\u00a0al. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Drug Alcohol Depend. 2017;181:223\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.032.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"465_CR80","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","volume":"161","author":"AJ Budney","year":"2004","unstructured":"Budney AJ. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161(11):1967\u201377. https:\/\/doi.org\/10.1176\/appi.ajp.161.11.1967.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"465_CR81","first-page":"270","volume":"51","author":"G Katz","year":"2014","unstructured":"Katz G, Lobel T, Tetelbaum A, Raskin S. Cannabis withdrawal\u2014a new diagnostic category in DSM-5. Isr J Psychiatry Relat Sci. 2014;51(4):270\u20135.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"9","key":"465_CR82","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.4088\/jcp.v69n0902","volume":"69","author":"DS Hasin","year":"2008","unstructured":"Hasin DS, Keyes KM, Alderson D, et\u00a0al. Cannabis withdrawal in the United States. J Clin Psychiatry. 2008;69(9):1354\u201363. https:\/\/doi.org\/10.4088\/jcp.v69n0902.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"465_CR83","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1360-0443.2008.02230.x","volume":"103","author":"J McLaren","year":"2008","unstructured":"McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction. 2008;103(7):1100\u20139. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02230.x.","journal-title":"Addiction"},{"issue":"4","key":"465_CR84","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327\u201360. https:\/\/doi.org\/10.2165\/00003088-200342040-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"465_CR85","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1503\/cmaj.191097","volume":"192","author":"T Antoniou","year":"2020","unstructured":"Antoniou T, Bodkin J, Ho JMW. Drug interactions with cannabinoids. CMAJ. 2020;192(9):E206. https:\/\/doi.org\/10.1503\/cmaj.191097.","journal-title":"CMAJ"},{"issue":"1","key":"465_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/2193-1801-2-236","volume":"2","author":"C Stott","year":"2013","unstructured":"Stott C, White L, Wright S, Wilbraham D, Guy G. A phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC\/CBD oromucosal spray in healthy volunteers. Springerplus. 2013;2(1):236. https:\/\/doi.org\/10.1186\/2193-1801-2-236.","journal-title":"Springerplus"},{"key":"465_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pharmthera.2019.05.001","volume":"201","author":"EJ Cox","year":"2019","unstructured":"Cox EJ, Maharao N, Patilea-Vrana G, et\u00a0al. A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics. Pharmacol Ther. 2019;201:25\u201338. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.001.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"465_CR88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40266-018-0616-5","volume":"36","author":"A Minerbi","year":"2018","unstructured":"Minerbi A, H\u00e4user W, Fizcharles M. Medical cannabis for older patients. Drugs Aging. 2018;36(1):39\u201351. https:\/\/doi.org\/10.1007\/s40266-018-0616-5.","journal-title":"Drugs Aging"},{"issue":"1","key":"465_CR89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12954-021-00520-5","volume":"18","author":"SL Kvamme","year":"2021","unstructured":"Kvamme SL, Pedersen MM, R\u00f8mer Thomsen K, Thylstrup B. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduct J. 2021;18(1):72. https:\/\/doi.org\/10.1186\/s12954-021-00520-5.","journal-title":"Harm Reduct J"},{"issue":"1","key":"465_CR90","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012","volume":"2","author":"A Reiman","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2(1):160\u20136. https:\/\/doi.org\/10.1089\/can.2017.0012.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"10","key":"465_CR91","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.mayocp.2021.05.005","volume":"96","author":"AI Perlman","year":"2021","unstructured":"Perlman AI, McLeod HM, Ventresca EC, et\u00a0al. Medical cannabis state and federal regulations: implications for United States health care entities. Mayo Clin Proc. 2021;96(10):2671\u201381. https:\/\/doi.org\/10.1016\/j.mayocp.2021.05.005.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"465_CR92","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2045125312457586","volume":"2","author":"Z Atakan","year":"2012","unstructured":"Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012;2(6):241\u201354. https:\/\/doi.org\/10.1177\/2045125312457586.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"188","key":"465_CR93","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.drugalcdep.2018.03.041","volume":"1","author":"MC Meacham","year":"2018","unstructured":"Meacham MC, Paul MJ, Ramo DE. Understanding emerging forms of cannabis use through an online cannabis community: an analysis of relative post volume and subjective highness ratings. Drug Alcohol Depend. 2018;1(188):364\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.041.","journal-title":"Drug Alcohol Depend"},{"key":"465_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.004.","journal-title":"Eur J Intern Med"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-022-00465-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-022-00465-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-022-00465-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T05:50:02Z","timestamp":1728712202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-022-00465-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1007\/s40122-022-00465-y","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}